ARTICLE | Clinical News
Gilenya fingolimod regulatory update
September 13, 2010 7:00 AM UTC
The Russian Federal Service on Surveillance in Healthcare and Social Development approved Gilenya fingolimod from Novartis to treat relapsing-remitting multiple sclerosis (RRMS). The company plans to ...